Verastem touts data from one early-stage trial, starts another
June 27, 2013 at 14:04 PM EDT
Verastem Inc. (Nasdaq: VSTM) in Cambridge has announced a spate of positive news in the past two weeks, which has contributed to the three-year-old biotech’s stock price increasing by more than a third...